Report period | 2019 | 2020 | 2021 | 2022 | 2023 | Q3 24 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
COO:US | Cooper Companies Inc. | Common share | - | US2166484020 | $100.4 |
Company name | Cooper Companies |
---|---|
Tags | #s&p500 index |
Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies |
Business address | 6140 STONERIDGE MALL RD STE 590 PLEASANTON CA 94588 9254603600 |
Mailing address | 6140 STONERIDGE MALL ROAD SUITE 590 PLEASANTON CA 94588 |
Website | www.coopercos.com |
Information disclosure | www.sec.gov |